GET THE APP

..

Neurological Disorders

ISSN: 2329-6895

Open Access

12th World Congress on Alzheimers Disease & Dementia January 23-24, 2020|Bangkok, Thailand

Abstract

Nasreen Sultana

Dementia, including Alzheimer's disease, is one of the best overall general prosperity challenges facing our period. Around the globe, no under 44 million people are living with dementia this number is depended upon to two overlaps by 2030 and more than triple by 2050 to 115 million. A critical piece of the development will be in making countries like Western Europe and North America. Authoritatively 62% of people with dementia live in making countries. Today, more than 35 million people general directly live with the condition. This number is depended upon to twofold by 2030 and more than triple by 2050 to 115 million. No drugs available to direct or stop the cerebrum hurt caused by Alzheimer's disease, a couple of pharmaceuticals can quickly help upgrade the symptoms of dementia for a couple of individuals. In two decades, it is assessed that 1.4 million Canadians will have dementia, costing the economy almost $300 billion consistently. Comprehensive, dementia cost $600 billion a year.

PDF

Share this article

Google Scholar citation report
Citations: 1343

Neurological Disorders received 1343 citations as per Google Scholar report

Neurological Disorders peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward